These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35924867)

  • 21. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012.
    Edgar JD; Buckland M; Guzman D; Conlon NP; Knerr V; Bangs C; Reiser V; Panahloo Z; Workman S; Slatter M; Gennery AR; Davies EG; Allwood Z; Arkwright PD; Helbert M; Longhurst HJ; Grigoriadou S; Devlin LA; Huissoon A; Krishna MT; Hackett S; Kumararatne DS; Condliffe AM; Baxendale H; Henderson K; Bethune C; Symons C; Wood P; Ford K; Patel S; Jain R; Jolles S; El-Shanawany T; Alachkar H; Herwadkar A; Sargur R; Shrimpton A; Hayman G; Abuzakouk M; Spickett G; Darroch CJ; Paulus S; Marshall SE; McDermott EM; Heath PT; Herriot R; Noorani S; Turner M; Khan S; Grimbacher B
    Clin Exp Immunol; 2014 Jan; 175(1):68-78. PubMed ID: 23841717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abstracts of the UKPIN (UK Primary Immunodeficiency Network) Immunology Forum. November 26-27, 2009. Bath, United Kingdom.
    Clin Exp Immunol; 2010 Apr; 160 Suppl 1(Suppl 1):1-20. PubMed ID: 20377611
    [No Abstract]   [Full Text] [Related]  

  • 23. Recommendations following a modified UK-Delphi consensus study on best practice for referral and management of severe asthma.
    Jackson DJ; Butler C; Chaudhuri R; Pink K; Niven R; Prigmore S; Renwick C; Calvert J
    BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34583985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7th International Immunoglobulin Conference: Immunodeficiencies.
    Schmidt RE; Ochs HD
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):3-4. PubMed ID: 25546741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology.
    Yong PL; Boyle J; Ballow M; Boyle M; Berger M; Bleesing J; Bonilla FA; Chinen J; Cunninghamm-Rundles C; Fuleihan R; Nelson L; Wasserman RL; Williams KC; Orange JS
    Clin Immunol; 2010 May; 135(2):255-63. PubMed ID: 19914873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus guidelines on the management of musculoskeletal infection affecting children in the UK.
    Mitchell PD; Abraham A; Carpenter C; Henman PD; Mavrotas J; McCaul J; Sanghrajka A; Theologis T;
    Bone Joint J; 2023 Jul; 105-B(7):815-820. PubMed ID: 37399098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing patients with side effects and adverse events to immunoglobulin therapy.
    Azizi G; Abolhassani H; Asgardoon MH; Shaghaghi S; Negahdari B; Mohammadi J; Rezaei N; Aghamohammadi A
    Expert Rev Clin Pharmacol; 2016; 9(1):91-102. PubMed ID: 26496172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study.
    Guerola LDC; Sacristán AAG; Portolés A; Jasso M; Guerra-Galán T; de la Fuente-Munoz E; Palacios-Ortega M; Fernández-Arquero M; Cuesta-Mínguez C; Rodríguez-Sanz A; Peña-Cortijo A; Polo M; Morales MM; Anguita-Mandly E; Benítez Jiménez T; Benavente Cuesta C; Sánchez-Ramón S
    Front Immunol; 2024; 15():1413231. PubMed ID: 38989286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7th International Immunoglobulin Conference: Poster presentations.
    Warnatz K; Ballow M; Stangel M; Bril V
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):162. PubMed ID: 25546805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin: a review.
    Eibl MM; Wedgwood RJ
    Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
    Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
    Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.
    Cinetto F; Neri R; Vianello F; Visentin A; Barilà G; Gianese S; Lanciarotta A; Milito C; Rattazzi M; Piazza F; Trentin L; Zambello R; Agostini C; Scarpa R
    PLoS One; 2021; 16(3):e0247717. PubMed ID: 33661940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice.
    Hackett G; Kirby M; Edwards D; Jones TH; Wylie K; Ossei-Gerning N; David J; Muneer A
    J Sex Med; 2017 Dec; 14(12):1504-1523. PubMed ID: 29198507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IUIS/WHO notice. Appropriate uses of human immunoglobulin in clinical practice.
    Clin Exp Immunol; 1983 May; 52(2):417-22. PubMed ID: 6861378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab and immune deficiency: case series and review of the literature.
    Kaplan B; Kopyltsova Y; Khokhar A; Lam F; Bonagura V
    J Allergy Clin Immunol Pract; 2014; 2(5):594-600. PubMed ID: 25213054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous immunoglobulin therapy home.
    Ozerovitch L
    Nurs Times; 2013 Dec 11-2014 Jan 14; 109(49-50):20-2. PubMed ID: 24568017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.
    Goudouris ES; Rego Silva AM; Ouricuri AL; Grumach AS; Condino-Neto A; Costa-Carvalho BT; Prando CC; Kokron CM; Vasconcelos DM; Tavares FS; Silva Segundo GR; Barreto IC; Dorna MB; Barros MA; Forte WCN
    Einstein (Sao Paulo); 2017; 15(1):1-16. PubMed ID: 28444082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spectrum of primary immunodeficiency disorders in Australia.
    Baumgart KW; Britton WJ; Kemp A; French M; Roberton D
    J Allergy Clin Immunol; 1997 Sep; 100(3):415-23. PubMed ID: 9314356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies].
    Krudewig J; Baumann U; Bernuth von H; Borte M; Burkhard-Meier U; Dueckers G; Foerster-Waldl E; Franke K; Habermehl P; Hönig M; Kern W; Kösters K; Kugel K; Lehrnbecher T; Liese J; Marks R; Müller GA; Müller R; Nadal D; Peter HH; Pfeiffer-Kascha D; Schneider M; Sitter H; Späth P; Wahn V; Welte T; Niehues T;
    Klin Padiatr; 2012 Oct; 224(6):404-15. PubMed ID: 23143768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study.
    Legendre P; Chahwan D; Marjanovic Z; Vignon M; Hermine O; Lortholary O; Morelle G; Darrodes M; Kahn JE; Ouzegdouh M; Chaibi P; Montestruc F; Caumont-Prim A; Le Jouan M; Hassani Y; Godeau B; Durand-Zaleski I; Mouthon L
    Clin Immunol; 2020 Jun; 215():108419. PubMed ID: 32289463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.